Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world.

Once the domain of science fiction, neurotechnology is a reality with enormous implications for medicine and the digital ...

Stock splits are typically viewed as bullish indicators that a company sees more growth is on the horizon. Although nothing ...

Me helped usher in the era of consumer DNA test kits nearly two decades ago, but has more recently faced a series of setbacks ...

The company’s valuation had dropped from $6 billion in 2021, to under $150 million after going public and when CEO Anne Wojcicki pushed for a plan to buy it and take it private, the board rejected her ...

Financial and security chaos at the once-pioneering genetic testing firm has intensified concerns about user data. Here's how ...

In 2009, Anne Wojcicki took a decisive step in her role as the leader of 23andMe, the genetic testing company she co-founded ...

Then plop the turkey in a roasting pan, spray or brush the turkey with oil then bake. No need to cover it for the first few ...

A huge data breach followed by a plummeting valuation has stoked fears of a sale of 23andMe along with all of its customers' genetic data.

Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world.

Me, one of the leading direct-to-consumer genetic testing companies, is on the verge of bankruptcy, raising concerns over the privacy and security of its vast genetic data repository. Customers are ...